Cargando…

Current clinical trials with non-coding RNA-based therapeutics in malignant diseases: A systematic review

This systematic review aimed to shed light on the trend of current clinical trials of non-coding RNA (ncRNA)-based therapeutics for malignant diseases. We conducted a database search for published literature and ongoing clinical trials using PubMed, clinicaltrials.gov, and University Medical Informa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ito, Masaoki, Miyata, Yoshihiro, Okada, Morihito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969060/ https://www.ncbi.nlm.nih.gov/pubmed/36841158 http://dx.doi.org/10.1016/j.tranon.2023.101634

Ejemplares similares

Pathological high malignant grade is higher risk of recurrence in pN0M0 invasive lung adenocarcinoma, even with small invasive size
por: Ito, Masaoki, et al.
Publicado: (2021)

Distribution and prognostic impact of EGFR and KRAS mutations according to histological subtype and tumor invasion status in pTis-3N0M0 lung adenocarcinoma
por: Ito, Masaoki, et al.
Publicado: (2023)

Different significance of HRCT and FDG-PET/CT to predict lymph node status between patients with clinical stage IA lung adenocarcinoma and squamous cell carcinoma
por: Tsutani, Yasuhiro, et al.
Publicado: (2015)

The safety and efficacy of fibrinogen and thrombin-based collagen fleece for treatment of pleural injury
por: Tsubokawa, Norifumi, et al.
Publicado: (2015)

Therapeutic strategies and genetic profile comparisons in small cell carcinoma and large cell neuroendocrine carcinoma of the lung using next-generation sequencing
por: Ito, Masaoki, et al.
Publicado: (2017)

Commentary: Segmentectomy as a standard surgery, a new era in small sized, peripheral, non–small cell lung cancer
por: Mimae, Takahiro, et al.
Publicado: (2022)

Identification of High-Risk of Recurrence in Clinical Stage I Non-Small Cell Lung Cancer
por: Tsutani, Yasuhiro, et al.
Publicado: (2021)

Increased risk of recurrence in resected EGFR‐positive pN0M0 invasive lung adenocarcinoma
por: Ito, Masaoki, et al.
Publicado: (2018)

The relationship between the malignancy grade of lung adenocarcinoma with micropapillary pattern and the findings of positron emission tomography
por: Tsubokawa, Norifumi, et al.
Publicado: (2015)

Segmentectomy versus wedge resection for radiological solid predominant and low metabolic non-small cell lung cancer
por: Kagimoto, Atsushi, et al.
Publicado: (2022)

Segmentectomy for clinically early‐stage primary squamous cell carcinoma of the lung
por: Kagimoto, Atsushi, et al.
Publicado: (2022)

Enhanced gefitinib‐induced repression of the epidermal growth factor receptor pathway by ataxia telangiectasia‐mutated kinase inhibition in non‐small‐cell lung cancer cells
por: Misumi, Keizo, et al.
Publicado: (2016)

Segmentectomy for cancer control in radiologically pure-solid clinical stage IA3 lung cancer
por: Kamigaichi, Atsushi, et al.
Publicado: (2023)

Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL)
por: Kagimoto, Atsushi, et al.
Publicado: (2021)

The intersegmental pulmonary vein is not always located on the intersegmental plane of the lung: Evaluation with 3-dimensional volume-rendering image reconstruction
por: Mimae, Takahiro, et al.
Publicado: (2022)

Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer
por: Furukawa, Takaoki, et al.
Publicado: (2015)

Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness
por: Mimae, Takahiro, et al.
Publicado: (2022)

Long non-coding RNA lnc-CHAF1B-3 as a new player in fibrosis
por: Sen, Ilayda, et al.
Publicado: (2023)

Small Non-Coding-RNA in Gynecological Malignancies
por: Dwivedi, Shailendra Kumar Dhar, et al.
Publicado: (2021)

Evolving Landscape of Initial Treatments for Patients with Malignant Pleural Mesotheliomas: Clinical Trials to Clinical Practice
por: Offin, Michael, et al.
Publicado: (2022)

Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter study
por: Isaka, Tetsuya, et al.
Publicado: (2023)

Extracellular vesicle-associated microRNA signatures related to lymphovascular invasion in early-stage lung adenocarcinoma
por: Shimada, Yoshihisa, et al.
Publicado: (2023)

Possible Therapeutic Utility of anti-Cell Adhesion Molecule 1 Antibodies for Malignant Pleural Mesothelioma
por: Hagiyama, Man, et al.
Publicado: (2022)

Stabilizing the Code—Methods to Preserve RNA Prove Their Worth
por: Williams, Marc A.
Publicado: (2010)

Application of PET/CT to adjuvant chemotherapy for early lung adenocarcinoma
por: Sasada, Shinsuke, et al.
Publicado: (2015)

Interstitial pneumonia and advanced age negatively influence postoperative pulmonary function
por: Mimae, Takahiro, et al.
Publicado: (2022)

Current Controlled Trials: an opportunity to help improve the quality of clinical research
por: Chalmers, Iain
Publicado: (2000)

The Interplay of Protein Coding and Non-Coding RNAs (circRNAs, lncRNAs) During Cardiac Differentiation
por: McMullen, Julie R., et al.
Publicado: (2017)

Highlights: Lymphoma microenvironment: Current progress of the tumor microenvironment in lymphoid malignancies
por: Karube, Kennosuke
Publicado: (2021)

MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications
por: Bravo-Vázquez, Luis Alberto, et al.
Publicado: (2022)

Wedge resection is an acceptable treatment option for radiologically low-grade lung cancer with solid predominance
por: Kamigaichi, Atsushi, et al.
Publicado: (2023)

Standardising outcomes for clinical trials and systematic reviews
por: Clarke, Mike
Publicado: (2007)

Korean clinical trials: its current status, future prospects, and enabling environment
por: Chee, Dong Hyun
Publicado: (2019)

Expression and therapeutic significance of estrogen receptor β in malignant pleural mesothelioma
por: Pinton, Giulia, et al.
Publicado: (2017)

Effect of Wnt5a on drug resistance in estrogen receptor-positive breast cancer
por: Amioka, Ai, et al.
Publicado: (2021)

Non-coding RNAs enter mitosis: functions, conservation and implications
por: Pek, Jun Wei, et al.
Publicado: (2011)

Long Non-Coding RNAs in Cardiac and Pulmonary Fibroblasts and Fibrosis
por: Ilieva, Mirolyuba, et al.
Publicado: (2022)

Unraveling the epitranscriptome of small non-coding RNAs in vascular cells
por: Caporali, Andrea, et al.
Publicado: (2022)

Unlocking the potential of non-coding RNAs in cancer research and therapy
por: Uppaluri, Kalyan Ram, et al.
Publicado: (2023)

Non-coding RNA therapeutics in cardiovascular diseases and risk factors: Systematic review
por: Ardiana, Meity, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mmg4timf2od1t0itjs2jnvqub8